New York State Common Retirement Fund Taysha Gene Therapies, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,100 shares of TSHA stock, worth $33,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,100
Previous 21,100
-0.0%
Holding current value
$33,971
Previous $42,000
11.9%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TSHA
# of Institutions
130Shares Held
151MCall Options Held
48KPut Options Held
7.8K-
Avoro Capital Advisors LLC New York, NY20MShares$32.2 Million0.5% of portfolio
-
Morgan Stanley New York, NY17.6MShares$28.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$18.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$17.5 Million0.3% of portfolio
-
Octagon Capital Advisors LP New York, NY10.5MShares$16.8 Million4.03% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $77.9M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...